Login / Signup

Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patients.

Brian T LeeMimi ChangCarolina LimHo S BaeTse-Ling Fong
Published in: JGH open : an open access journal of gastroenterology and hepatology (2020)
CHB patients who switch from long-term TDF to TAF therapy show sustained improvement in proximal tubular function and hip BMD. Weight gain was noted, and long-term studies are needed to evaluate its effect on patient outcomes.
Keyphrases